Diagram illustrating the androgen-mediated signal transduction via integrins and the resulting biological activities
Diagram illustrating the androgen-mediated signal transduction via integrins and the resulting biological activities. (A) Integrin-induced cell motility and adhesion are mediated by AR. Activation of iAR by DHT or R1881 affects different subtypes of integrin expression to regulate cell adhesion and motility. RANK/RANKL promotes iAR expression through integrin α2β1 and induces integrin α2β1-involved cell adhesion via FAK/Akt signaling pathway. In AR-expressing cells, FAK signaling modulates integrin α5β1-induced cell adhesion and integrin αv-induced cell motility. (B) Integrin-induced cell growth and survival are mediated by AR. Activation of iAR by R1881 induces the expression of integrin α6β1, which in turn regulates cell survival through HIF-1α-promoted BNIP3 expression. Furthermore, iAR activity is up-regulated by integrin αvβ6, leading to increased survivin expression and enhanced cell growth. The activation of IGF-IR suppresses the degradation of integrin α5β1 through endocytosis, allowing this remaining integrin α5β1 to induce cell growth. The brown arrows indicate RANK/integrin α2β1/ transcription factor (TF)/iAR and RANK/integrin α2β1/FAK/Akt pathways; The dark blue arrows indicate integrin α5β1/FAK/Akt pathway; The purple arrows indicate integrin αv/FAK/mTOR pathway; The light blue arrows indicate IGF-1R/ integrin α5β1 pathway; The red arrows indicate R1881/iAR/integrin α6β1 pathway; The green arrows indicate integrin αvβ6/JNK/iAR (activity)/survivin pathway; The orange arrows indicate integrin α6β1/HIF-1α/BNIP3 pathway
Publication
Integrins and Actions of Androgen in Breast Cancer (2023) Chung-Che Tsai, et al. Cells. 2023 Sep;12(17). Figure: F3.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | RANKL | RANKL | ncbigene_synonym | TNFSF11 | 8600 |
| Homo sapiens | Primates | B1 | B1 | ncbigene_synonym | B3GNT2 | 10678 |
| Homo sapiens | Primates | B1 | B1 | ncbigene_synonym | B3GNTL1 | 146712 |
| Homo sapiens | Primates | RANK | RANK | ncbigene_synonym | TNFRSF11A | 8792 |
| Homo sapiens | Primates | IAR | IAR | ncbigene_synonym | PTPRN2 | 5799 |
| Homo sapiens | Primates | TF | TF | ncbigene_symbol | TF | 7018 |
| Homo sapiens | Primates | FAK | FAK | ncbigene_synonym | PTK2 | 5747 |
| Homo sapiens | Primates | Akt | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | Akt | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | Akt | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | mTOR | MTOR | ncbigene_symbol | MTOR | 2475 |
| Homo sapiens | Primates | a2ẞ1 | A21 | ncbigene_synonym | IGKV2-26 | 28922 |
| Homo sapiens | Primates | MUC1 | MUC1 | ncbigene_symbol | MUC1 | 4582 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| R1881 | R1881 | 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | chebi:379896 | |
| DHT | DHT | 17beta-hydroxy-5alpha-androstan-3-one | chebi:16330 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|